|For adults ≥40 years with low fracture risk, we strongly recommend against OP medications due to known risk of harms and no evidence of benefit.|Very low|4.4a–4.13a|91–101|
|Adults receiving high-dose GC (initial dose≥30 mg/day for &gt;30 days or cumulative dose ≥5 g in 1 year) We conditionally recommend treating with PTH/PTHrP over anti-resorptives.|Low|6.1b–6.19a|120–141|
|Oral BP are strongly recommended over no treatment.|Low|6.1b–6.19a|120–141|
|IV BP and DEN are conditionally recommended over no treatment.|Low|6.1b–6.19a|120–141|
|RAL and ROM are conditionally recommended in those intolerant of other agents.|Low|6.1b–6.19a|120–141|
|In adults &lt;40 years† Adults &lt;40 years with moderate fracture risk, we conditionally recommend oral or IV BP,¶ DEN,¶or PTH/PTHrP therapy.|Low or very low|2.4–2.22, 3.4–3.17|65–76, 79–84|